WFG Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$329K Hold
2,040
0.07% 270
2017
Q1
$315K Hold
2,040
0.08% 251
2016
Q4
$239K Hold
2,040
0.06% 333
2016
Q3
$230K Hold
2,040
0.06% 331
2016
Q2
$189K Hold
2,040
0.05% 358
2016
Q1
$160K Hold
2,040
0.05% 356
2015
Q4
$149K Hold
2,040
0.04% 367
2015
Q3
$151K Sell
2,040
-200
-9% -$14.3K 0.05% 352
2015
Q2
$144K Hold
2,240
0.04% 428
2015
Q1
$173K Sell
2,240
-200
-8% -$15.6K 0.05% 390
2014
Q4
$181K Hold
2,440
0.04% 460
2014
Q3
$144K Hold
2,440
0.03% 536
2014
Q2
$163K Hold
2,440
0.03% 500
2014
Q1
$148K Hold
2,440
0.03% 509
2013
Q4
$130K Hold
2,440
0.02% 646
2013
Q3
$122K Hold
2,440
0.02% 640
2013
Q2
$109K Buy
+2,440
New +$107K 0.02% 637

Other funds holding IDXX

WFG Advisors's IDXX Position: Q2 2017 in Review

WFG Advisors held its Idexx Laboratories (IDXX) position steady in Q2 2017 at 2,040 shares worth $329K. The position accounts for 0.07% of the portfolio, ranked #270.

WFG Advisors first reported a position in IDXX in Q2 2013 and has held it in 17 quarters since. 582 funds tracked by Wall St. Rank hold IDXX as of Q2 2017.

  • WFG Advisors held 2,040 shares of Idexx Laboratories worth $329K as of Q2 2017.
  • WFG Advisors left its Idexx Laboratories share count unchanged in Q2 2017.
  • Idexx Laboratories made up 0.07% of WFG Advisors's portfolio in Q2 2017, its #270 holding.
  • WFG Advisors first reported a position in Idexx Laboratories in Q2 2013 and has held it in 17 quarters since.
  • 582 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.